MICHAEL JOHNSON to Databases, Factual
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Databases, Factual.
Connection Strength
0.706
-
Comparative effectiveness research: guidelines for good practices are just the beginning. Expert Rev Pharmacoecon Outcomes Res. 2011 Feb; 11(1):51-7.
Score: 0.246
-
Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2- metastatic breast cancer in the United States. Breast Cancer Res Treat. 2023 Feb; 198(1):159-166.
Score: 0.140
-
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III. Value Health. 2009 Nov-Dec; 12(8):1062-73.
Score: 0.056
-
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Value Health. 2009 Nov-Dec; 12(8):1044-52.
Score: 0.056
-
Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II. Value Health. 2009 Nov-Dec; 12(8):1053-61.
Score: 0.056
-
Propensity score analysis in observational studies: outcomes after abdominal aortic aneurysm repair. Am J Surg. 2006 Sep; 192(3):336-43.
Score: 0.045
-
Real-world treatment patterns in drug na?ve type 2 diabetes population: Initial combination therapy vs. sequential step-therapy. J Am Pharm Assoc (2003). 2025 Jan-Feb; 65(1):102295.
Score: 0.040
-
Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017 Jul - Aug; 13(4):857-863.
Score: 0.023
-
Risk of serious cardiac events in older adults using antipsychotic agents. Am J Geriatr Pharmacother. 2011 Apr; 9(2):120-32.
Score: 0.016
-
Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry. 2010 Jun; 71(6):689-98.
Score: 0.015
-
Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol. 2010; 23(3):145-51.
Score: 0.014